Making explorers dreams happen

We create value for the life science industry by rapidly identifying and delivering clinical development solutions.

Solutions

Search our services by patient access or therapeutic areas

Mary-Claire King is an American geneticist. She is widely celebrated for identifying the inherited breast and ovarian cancer genes, BRCA1 and BRCA2. Her discoveries led to major developments in genetics long before scientists completed mapping the human genome.

Mary-Claire King (1946-),
American geneticist.

Career seekers

Make an impact on the livelihood and wellbeing of people.

Every day.

Join us

Investigative site network

We value your contribution to improving healthcare.

Worldwide.

Apply as a site

Patients

Discover the world of clinical trials.

From the patient perspective.

Learn more about the patient experience
“For us, innovation is a development strategy that allows us to differentiate our service offerings by including the most advanced technology in a sensible and responsible manner.”
Mike Jagielski, KCR CEO
“Modern R&D is certainly continuing to push the bar for the application of innovative therapies. (…) Consulting options are readily available and provide access to like-minded teams that can facilitate development at the right pace and an acceptable cost.”
Anna Baran, KCR CMO
“My ultimate hope working as a CTO for a growing and successful CRO is that we see a new DCT solution that builds from a core platform and then leverages this core in the development of component parts in order to achieve a true clinical trial lifecycle… for all stakeholders.”
Doug Bain, KCR CTO
  • Applied Clinical Trials
  • MassBio
  • Medium

We use cookies to run our website and improve our visitors’ experience. For more information see our Privacy Policy & Cookies Policy.

I agree. Do not show this message anymore.